RECRUITINGOBSERVATIONAL
Genetic Polymorphisms in Idiopathic Pulmonary Fibrosis (IPF)
Genetic Polymorphisms in Idiopathic Pulmonary Fibrosis
About This Trial
The purposes of this study are: * to determine if there are specific genetic traits that might explain why patients have developed pulmonary fibrosis; * to determine if specific genetic traits account for differing patterns of inflammation and scar tissue that has formed in the patient's lungs.
Who May Be Eligible (Plain English)
Who May Qualify:
- 18 years of age or older
- Diagnosis of pulmonary fibrosis confirmed by physical examination, pulmonary function testing, chest X-ray, and computed tomography (CT) scans.
- Adult patients who are seeking treatment at the Dorothy P. and Richard P. Simmons Center for Interstitial Lung Disease.
Who Should NOT Join This Trial:
- Under 18 years of age
- Non-fibrotic ILD
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* 18 years of age or older
* Diagnosis of pulmonary fibrosis confirmed by physical examination, pulmonary function testing, chest X-ray, and computed tomography (CT) scans.
* Adult patients who are seeking treatment at the Dorothy P. and Richard P. Simmons Center for Interstitial Lung Disease.
Exclusion Criteria:
* Under 18 years of age
* Non-fibrotic ILD
Locations (1)
University of Pittsburgh
Pittsburgh, Pennsylvania, United States